Mdm2 links genotoxic stress and metabolism to p53

被引:22
|
作者
Wang, Zhongfeng [1 ]
Li, Baojie [1 ]
机构
[1] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Ctr, Shanghai 200240, Peoples R China
关键词
mouse double minute 2 (Mdm2); p53; signal transduction; tumorigenesis;
D O I
10.1007/s13238-010-0140-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mouse double minute 2 (Mdm2) gene was isolated from a cDNA library derived from transformed mouse 3T3 cells, and was classified as an oncogene as it confers 3T3 and Rat2 cells tumorigenicity when overexpressed. It encodes a nucleocytoplasmic shuttling ubiquitin E3 ligase, with its main target being tumor suppressor p53, which is mutated in more than 50% of human primary tumors. Mdm2's oncogenic activity is mainly mediated by p53, which is activated by various stresses, especially genotoxic stress, via Atm (ataxia telangiectasia mutated) and Atr (Atm and Rad3-related). Activated p53 inhibits cell proliferation, induces apoptosis or senescence, and maintains genome integrity. Mdm2 is also a target gene of p53 transcription factor. Thus, Mdm2 and p53 form a feedback regulatory loop. External and internal cues, through multiple signaling pathways, can act on Mdm2 to regulate p53 levels and cell proliferation, death, and senescence. This review will focus on how Mdm2 is regulated under genotoxic stress, and by the Akt1-mTOR-S6K1 pathway that is activated by insulin, growth factors, amino acids, or energy status.
引用
收藏
页码:1063 / 1072
页数:10
相关论文
共 50 条
  • [21] A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma
    Jablkowski, M
    Bocian, A
    Bialkowska, J
    Bartkowiak, J
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (01): : 117 - 125
  • [22] Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    D Chen
    Z Zhang
    M Li
    W Wang
    Y Li
    E R Rayburn
    D L Hill
    H Wang
    R Zhang
    Oncogene, 2007, 26 : 5029 - 5037
  • [23] A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control
    Li, LM
    Liao, J
    Ruland, J
    Mak, TW
    Cohen, SN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1619 - 1624
  • [24] p53 ubiquitination by Mdm2: A never ending tail?
    Coutts, Amanda S.
    Adams, Cassandra J.
    La Thangue, Nicholas B.
    DNA REPAIR, 2009, 8 (04) : 483 - 490
  • [25] p53 and MDM2 expression in odontogenic cysts and tumours
    Carvalhais, JN
    de Aguiar, MCF
    de Araújo, VC
    de Araújo, NS
    Gomez, RS
    ORAL DISEASES, 1999, 5 (03) : 218 - 222
  • [26] The expression of MDM2 and p53 protein breast carcinoma
    Hideshima, T
    Shinohara, T
    Baba, M
    Shirakusa, T
    ONCOLOGY REPORTS, 1997, 4 (02) : 297 - 300
  • [27] Regulation of p53: a collaboration between Mdm2 and MdmX
    Pei, Dongsheng
    Zhang, Yanping
    Zheng, Junnian
    ONCOTARGET, 2012, 3 (03) : 228 - 235
  • [28] OVEREXPRESSION OF P53 AND MDM2 PROTEINS IN CERVICAL NEOPLASIA
    LUKAS, Z
    VOJTESEK, B
    ANTON, M
    PICKSLEY, SM
    KUBALEK, V
    FOLIA BIOLOGICA, 1995, 41 (3-4) : 197 - &
  • [29] Mdm2 association with p53 targets its ubiquitination
    Fuchs, SY
    Adler, V
    Buschmann, T
    Wu, XW
    Ronai, Z
    ONCOGENE, 1998, 17 (19) : 2543 - 2547
  • [30] MDM2 and MDMX: alone and together in regulation of p53
    Shadfan, Miriam
    Lopez-Pajares, Vanessa
    Yuan, Zhi-Min
    TRANSLATIONAL CANCER RESEARCH, 2012, 1 (02) : 88 - 99